Role of Ceruloplasmin in Diagnosing and Treating Wilson's Disease

Diagnostic Value of Ceruloplasmin

Ceruloplasmin measurement alone is insufficient for diagnosing Wilson's disease, with a positive predictive value of only 6% when used as a single screening test, but it remains a critical component of diagnostic algorithms when combined with other tests 1, 2
Ceruloplasmin is typically decreased in Wilson's disease, but this finding alone has significant limitations 1
Normal ceruloplasmin concentration measured by enzymatic assay varies among laboratories with a lower limit between 0.15-0.2 g/L 1
In Wilson's disease, ceruloplasmin is usually lower than 0.1 g/L, contributing 2 points in the Leipzig diagnostic scoring system 3
Ceruloplasmin may be in the low normal range in about half of patients with active Wilson's liver disease 1
False negatives: Normal ceruloplasmin levels can occur in patients with marked hepatic inflammation 2
False positives: Low ceruloplasmin can occur in malabsorption, aceruloplasminemia, and heterozygotes for Wilson's disease 2
15-36% of children with Wilson's disease had ceruloplasmin in the normal range 1
The predictive value of ceruloplasmin for diagnosis of Wilson's disease in acute liver failure is poor 1

Ceruloplasmin is a key component of the Leipzig scoring system for Wilson's disease diagnosis 3
The Leipzig scoring system assigns points as follows:
A total score of 4 or more establishes the diagnosis, 3 indicates possible diagnosis requiring more tests, and 2 or less makes the diagnosis very unlikely 3, 1

Ceruloplasmin levels are not typically used to monitor treatment response 4
Instead, non-ceruloplasmin-bound copper (free copper) is more valuable in monitoring pharmacotherapy than in diagnosis 4
Free copper can be calculated by subtracting ceruloplasmin-bound copper from total serum copper concentration 4
Target for free serum copper during treatment is <10 μg/dL 5

When Wilson's disease is diagnosed (partly based on low ceruloplasmin), treatment with copper chelating agents like D-penicillamine or trientine is indicated 5
Initial D-penicillamine dosage should be 250 mg/day, gradually increasing to 0.75-1.5 g/day 5
Treatment response should be monitored through 24-hour urinary copper excretion (target: >2 mg in first week) and long-term monitoring of free serum copper <10 μg/dL 5